Attenuation of thrombosis and bacterial infection using dual function nitric oxide releasing central venous catheters in a 9 day rabbit model

Acta Biomaterialia

Volumn 44, Issue , 2016, Pages 304-312

  Brisbois, Elizabeth J ^a   Major, Terry C ^a   Goudie, Marcus J ^b   Meyerhoff, Mark E ^c   Bartlett, Robert H ^a   Handa, Hitesh ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b University of Georgia   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antibacterial; Catheters; Hemocompatibility; Nitric oxide; Poly (lactide co glycolide)

Indexed keywords

ADDITIVES; ADHESION; ANTIMICROBIAL AGENTS; FUNCTIONAL POLYMERS; NITRIC OXIDE; PLATELETS;

ANTIBACTERIALS; BACTERIAL INFECTIONS; HAEMOCOMPATIBILITY; NITRIC OXIDE RELEASE; POLY (LACTIDE-CO-GLYCOLIDE); POLY LACTIC-CO-GLYCOLIC ACID; POLY LACTIDE-CO-GLYCOLIDE; POLY(LACTIC-CO-GLYCOLIC ACID); POLY-LACTIDE-CO-GLYCOLIDE; POLYLACTIDE-CO-GLYCOLIDE;

CATHETERS;

DIBUTYLHEXANEDIAMINE; ESTER; NITRIC OXIDE; POLYGLACTIN; POLYMER; POLYURETHAN; UNCLASSIFIED DRUG; DIAMINE; LACTIC ACID; N,N'-DIBUTYL-1,6-HEXANEDIAMINE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL EVALUATION; CONTROLLED STUDY; CYTOTOXICITY; INFECTION PREVENTION; NANOFABRICATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RABBIT; THROMBOCYTE ACTIVATION; THROMBOSIS; ANIMAL; BACTERIAL COUNT; BACTERIAL INFECTIONS; CHEMISTRY; COMPLICATION; HEMOLYSIS; LEPORIDAE; METABOLISM; MICROBIOLOGY;

ANIMALS; BACTERIAL ADHESION; BACTERIAL INFECTIONS; CENTRAL VENOUS CATHETERS; COLONY COUNT, MICROBIAL; DIAMINES; HEMOLYSIS; LACTIC ACID; NITRIC OXIDE; POLYGLYCOLIC ACID; RABBITS; THROMBOSIS;

EID: 84981747468     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2016.08.009     Document Type: Article

References (52)

1. [1] Ratner, B.D., The catastrophe revisited: blood compatibility in the 21st century. Biomaterials 28 (2007), 5144–5147.
2. [2] Brisbois, E.J., Davis, R.P., Jones, A.M., Major, T.C., Bartlett, R.H., Meyerhoff, M.E., Handa, H., Reduction in thrombosis and bacterial adhesion with 7 day implantation of S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As catheters in sheep. J. Mater. Chem. B, 2015.
3. [3] Robinson, T., Kickler, T.S., Walker, L.K., Ness, P., Bell, W., Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit. Care Med. 21 (1993), 1029–1034.
4. [4] Dillon, P.A., Foglia, R.P., Complications associated with an implantable vascular access device. J. Pediatr. Surg. 41 (2006), 1582–1587.
5. [5] Gaffney, A.M., Wildhirt, S.M., Griffin, M.J., Annich, G.M., Radomski, M.W., Extracorporeal life support. BMJ, 341, 2010, c5317-c.
6. [6] Vertes, A., Hitchins, V., Phillips, K.S., Analytical challenges of microbial biofilms on medical devices. Anal. Chem. 84 (2012), 3858–3866.
7. [7] Casey, L., A, SJ Elliott T. Prevention of central venous catheter-related infection: update. Br. J. Nurs. 19 (2010), 78–87.
8. [8] O'Grady, N.P., Alexander, M., Dellinger, E.P., Gerberding, J.L., Heard, S.O., Maki, D.G., Masur, H., McCormick, R.D., Mermel, L.A., Pearson, M.L., Guidelines for the prevention of intravascular catheter–related infections. Clin. Infect. Dis. 35 (2002), 1281–1307.
9. [9] Kluger, D., Maki, D., The relative risk of intravascular device related bloodstream infections in adults. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco, 1999, American Society for Microbiology, CA.
10. [10] Sunenshine, R.H., Wright, M.-O., Maragakis, L.L., Harris, A.D., Song, X., Hebden, J., Cosgrove, S.E., Anderson, A., Carnell, J., Jernigan, D.B., Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg. Infect. Dis. 13 (2007), 97–103.
11. [11] Dijkshoorn, L., Nemec, A., Seifert, H., An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5 (2007), 939–951.
12. [12] Høiby, N., Ciofu, O., Johansen, H.K., Song, Z.-J., Moser, C., Jensen, P.Ø., Molin, S., Givskov, M., Tolker-Nielsen, T., Bjarnsholt, T., The clinical impact of bacterial biofilms. Int. J. Oral Sci., 3, 2011, 55.
13. [13] Alcantar, N.A., Aydil, E.S., Israelachvili, J.N., Polyethylene glycol-coated biocompatible surfaces. J. Biomed. Mater. Res. 51 (2000), 343–351.
14. [14] Holmberg, K., Bergström, K., Stark, M.-B., Immobilization of proteins via PEG chains. Poly (Ethylene Glycol) Chemistry, 1992, Springer, 303–324.
15. [15] Gölander, C.-G., Herron, J.N., Lim, K., Claesson, P., Stenius, P., Andrade, J., Properties of immobilized PEG films and the interaction with proteins. Poly (Ethylene Glycol) Chemistry, 1992, Springer, 221–245.
16. [16] Lee, J.H., Lee, H.B., Andrade, J.D., Blood compatibility of polyethylene oxide surfaces. Prog. Polym. Sci. 20 (1995), 1043–1079.
17. [17] Andrade, J., Hlady, V., Jeon, S.-I., Polyethylene oxide and protein resistance: principles, problems, and possibilities. Polym. Mater. Sci. Eng., 1993, 60–61.
18. [18] Harris, J.M., Poly (Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications. 1992, Springer Science & Business Media.
19. [19] Brisbois, E.J., Handa, H., Meyerhoff, M.E., Recent advances in hemocompatible polymers for biomedical applications. Advanced Polymers in Medicine, 2015, Springer, 481–511.
20. [20] Aksoy, A.E., Hasirci, V., Hasirci, N., Surface Modification of Polyurethanes With Covalent Immobilization of Heparin. Macromolecular Symposia. 2008, Wiley Online Library, 145–153.
21. [21] Basmadjian, D., Sefton, M., Relationship between release rate and surface concentration for heparinized materials. J. Biomed. Mater. Res. 17 (1983), 509–518.
22. [22] Kang, I.-K., Kwon, O.H., Kim, M.K., Lee, Y.M., Sung, Y.K., In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma glow discharge. Biomaterials 18 (1997), 1099–1107.
23. [23] Liang, Y., Kiick, K.L., Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications. Acta Biomater. 10 (2014), 1588–1600.
24. [24] Zhou, Z., Meyerhoff, M.E., Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin. Biomaterials 26 (2005), 6506–6517.
25. [25] Chen, Y.-M., Dai, A.-P., Shi, Y., Liu, Z.-J., Gong, M.-F., Yin, X.-B., Effectiveness of silver-impregnated central venous catheters for preventing catheter-related blood stream infections: a meta-analysis. Int. J. Infect. Dis. 29 (2014), 279–286.
26. [26] Radomski, M.W., Palmer, R.M., Moncada, S., The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun. 148 (1987), 1482–1489.
27. [27] Vaughn, M.W., Kuo, L., Liao, J.C., Estimation of nitric oxide production and reactionrates in tissue by use of a mathematical model. Am. J. Physiol. 274 (1998), H2163–H2176.
28. [28] Regev-Shoshani, G., Ko, M., Miller, C., Av-Gay, Y., Slow release of nitric oxide from charged catheters and its effect on biofilm formation by Escherichia coli. Antimicrob. Agents Chemother. 54 (2010), 273–279.
29. [29] Ren, H., Colletta, A., Koley, D., Wu, J., Xi, C., Major, T.C., Bartlett, R.H., Meyerhoff, M.E., Thromboresistant/anti-biofilm catheters via electrochemically modulated nitric oxide release. Bioelectrochemistry, 2014.
30. [30] Nablo, B.J., Chen, T.-Y., Schoenfisch, M.H., Sol-gel derived nitric-oxide releasing materials that reduce bacterial adhesion. J. Am. Chem. Soc. 123 (2001), 9712–9713.
31. [31] Nablo, B.J., Schoenfisch, M.H., Antibacterial properties of nitric oxide–releasing sol-gels. J. Biomed. Mater. Res., Part A 67 (2003), 1276–1283.
32. [32] Martinez, L.R., Han, G., Chacko, M., Mihu, M.R., Jacobson, M., Gialanella, P., Friedman, A.J., Nosanchuk, J.D., Friedman, J.M., Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J. Invest. Dermatol. 129 (2009), 2463–2469.
33. [33] de Souza, G.F.P., Yokoyama-Yasunaka, J.K.U., Seabra, A.B., Miguel, D.C., de Oliveira, M.G., Uliana, S.R.B., Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis. Nitric Oxide 15 (2006), 209–216.
34. [34] Seabra, A.B., de Souza, G.F.P., da Rocha, L.L., Eberlin, M.N., de Oliveira, M.G., S-Nitrosoglutathione incorporated in poly(ethylene glycol) matrix: potential use for topical nitric oxide delivery. Nitric Oxide 11 (2004), 263–272.
35. [35] Annich, G.M., Meinhardt, J.P., Mowery, K.A., Ashton, B.A., Merz, S.I., Hirschl, R.B., Meyerhoff, M.E., Bartlett, R.H., Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers. Crit. Care Med. 28 (2000), 915–920.
36. [36] Schoenfisch, M.H., Mowery, K.A., Rader, M.V., Baliga, N., Wahr, J.A., Meyerhoff, M.E., Improving the thromboresistivity of chemical sensors via nitric oxide release: fabrication and in vivo evaluation of NO-releasing oxygen-sensing catheters. Anal. Chem. 72 (2000), 1119–1126.
37. [37] Goudie, M.J., Brisbois, E.J., Pant, J., Thompson, A., Potkay, J.A., Handa, H., Characterization of an S-nitroso-N-acetylpenicillamine–based nitric oxide releasing polymer from a translational perspective. Int. J. Polym. Mater. Polym. Biomater. 65 (2016), 769–778.
38. [38] Major, T.C., Brant, D.O., Reynolds, M.M., Bartlett, R.H., Meyerhoff, M.E., Handa, H., Annich, G.M., The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer. Biomaterials 31 (2010), 2736–2745.
39. [39] Handa, H., Major, T.C., Brisbois, E.J., Amoako, K.A., Meyerhoff, M.E., Bartlett, R.H., Hemocompatibility comparison of biomedical grade polymers using rabbit thrombogenicity model for preparing nonthrombogenic nitric oxide releasing surfaces. J. Mater. Chem. B 2 (2014), 1059–1067.
40. [40] Handa, H., Brisbois, E.J., Major, T.C., Refahiyat, L., Amoako, K.A., Annich, G.M., Bartlett, R.H., Meyerhoff, M.E., In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-doped poly (vinyl chloride) matrix with poly (lactide-co-glycolide) additive. J. Mater. Chem. B 1 (2013), 3578–3587.
41. [41] Cai, W., Wu, J., Xi, C., Meyerhoff, M.E., Diazeniumdiolate-doped poly (lactic-co-glycolic acid)-based nitric oxide releasing films as antibiofilm coatings. Biomaterials 33 (2012), 7933–7944.
42. [42] Batchelor, M.M., Reoma, S.L., Fleser, P.S., Nuthakki, V.K., Callahan, R.E., Shanley, C.J., Politis, J.K., Elmore, J., Merz, S.I., Meyerhoff, M.E., More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 46 (2003), 5153–5161.
43. [43] Wu, B., Development of hemocompatible polymeric materials for blood-contacting medical devices. PhD Dissertation, 2009, University of Michigan, Ann Arbor.
44. [44] Brisbois, E.J., Bayliss, J., Wu, J., Major, T.C., Xi, C., Wang, S.C., Bartlett, R.H., Handa, H., Meyerhoff, M.E., Optimized polymeric film-based nitric oxide delivery inhibits bacterial growth in a mouse burn wound model. Acta Biomater. 10 (2014), 4136–4142.
45. [45] Batchelor, M.M., Reoma, S.L., Fleser, P.S., Nuthakki, V.K., Callahan, R.E., Shanley, C.J., Politis, J.K., Elmore, J., Merz, S.I., Meyerhoff, M.E., More lipophilic dialkyldiamine-based diazeniumdiolates: synthesis, characterization, and application in preparing thromboresistant nitric oxide release polymeric coatings. J. Med. Chem. 46 (2003), 5153–5161.
46. [46] Klement, P., Du, Y.J., Berry, L.R., Tressel, P., Chan, A.K.C., Chronic performance of polyurethane catheters covalently coated with ATH complex: a rabbit jugular vein model. Biomaterials 27 (2006), 5107–5117.
47. [47] Simmons, A., Padsalgikar, A.D., Ferris, L.M., Poole-Warren, L.A., Biostability and biological performance of a PDMS-based polyurethane for controlled drug release. Biomaterials 29 (2008), 2987–2995.
48. [48] Cozzens, D., Luk, A., Ojha, U., Ruths, M., Faust, R., Surface characterization and protein interactions of segmented polyisobutylene-based thermoplastic polyurethanes. Langmuir 27 (2011), 14160–14168.
49. [49] Major, T.C., Brisbois, E.J., Jones, A.M., Zanetti, M.E., Annich, G.M., Bartlett, R.H., Handa, H., The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation. Biomaterials 35 (2014), 7271–7285.
50. [50] Shenderova, A., Ding, A.G., Schwendeman, S.P., Potentiometric method for determination of microclimate pH in poly (lactic-co-glycolic acid) films. Macromolecules 37 (2004), 10052–10058.
51. [51] Brisbois, E.J., Handa, H., Major, T.C., Bartlett, R.H., Meyerhoff, M.E., Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer. Biomaterials 34 (2013), 6957–6966.
52. [52] Lantvit, S.M., Barrett, B.J., Reynolds, M.M., Nitric oxide releasing material adsorbs more fibrinogen. J. Biomed. Mater. Res., Part A 101 (2013), 3201–3210.